Results 271 to 280 of about 2,643,192 (369)

Development of 4T1 breast cancer mouse model system for preclinical carbonic anhydrase IX studies

FEBS Open Bio, EarlyView.
Carbonic anhydrase IX (CAIX) is a well‐recognised therapeutic target and prognostic biomarker in cancer. We developed and characterised a robust murine breast cancer model system that is suitable for CAIX studies in vitro and in vivo—it comprises both CAIX‐positive and CAIX‐negative controls and provides a solid platform for the comprehensive ...
Zane Kalniņa, Ilva Liekniņa, Svetlana Koteloviča, Ramona Petrovska, Gediminas Žvinys, Agne Petrosiute, Asta Zubrienė, Matīss Toms Laugalis, Vendija Skeltona, Juris Jansons, Madara Kreishmane, Edita Čapkauskaitė, Daumantas Matulis, Kaspars Tārs   +13 more
wiley   +1 more source

Combination Therapy with Cyclosporine and Methotrexate in Severe Rheumatoid Arthritis [PDF]

, 1995
Peter Tugwell, Theodore Pincus, David E. Yocum, Michael Ashley Stein, Oscar Gluck, G Kraag, R J McKendry, John Tesser, P. D. Baker, George A. Wells   +9 more
openalex   +1 more source

Transferrin-Liposome-Mediated Systemic p53 Gene Therapy in Combination with Radiation Results in Regression of Human Head and Neck Cancer Xenografts [PDF]

, 1999
Liang Xu, Kathleen F. Pirollo, Wenhua Tang, Antonina Rait, Esther H. Chang   +4 more
openalex   +1 more source

Understanding and Overcoming Immunotherapy Resistance in Skin Cancer: Mechanisms and Strategies

Aging and Cancer, EarlyView.
This narrative review explores the mechanisms driving immunotherapy resistance in skin cancer, including tumor microenvironment factors, genetic mutations, and immune evasion strategies. It highlights potential strategies to overcome resistance, offering insights for improving therapeutic outcomes and guiding future research in personalized ...
Shreya Singh Beniwal, Abhimanyu Chiraparambil Radhakrishnan, Ayanchetty Haripraba, Saif Syed, Gajawada Pragna, Ayush Dwivedi, Akash Rawat, Daniela Castro Calderón, Martin Cevallos‐Cueva   +8 more
wiley   +1 more source

Strengths, weaknesses, opportunities, and threats analysis of combination therapy for inflammatory bowel disease. [PDF]

World J Gastroenterol
Yan JW, Nie M, Zhang H, Liu YM, Tang FS.
europepmc   +1 more source

Aging‐Driven Blood–Brain Barrier Dysfunction and Its Impact on CNS Cancer Susceptibility: A Comprehensive Narrative Review

Aging and Cancer, EarlyView.
Aging weakens the blood–brain barrier (BBB), increasing susceptibility to CNS cancers and complicating treatment. This review examines BBB deterioration, its impact on drug delivery, and potential interventions like targeting neuroinflammation and advanced therapies.
Quang La, Aiman Baloch, David F. Lo
wiley   +1 more source

Editorial: Enhancing innate immunity in combination therapy for solid tumors. [PDF]

Front Immunol
Pejoski D.
europepmc   +1 more source

EVIDENCE THAT COMBINATION THERAPY USING COBRA VENOM FACTOR, SPLENECTOMY, AND DEOXYSPERGUALIN IS EFFECTIVE IN GUINEA PIG TO RAT CARDIAC XENOTRANSPLANTATION1

, 1994
NULL AUTHOR_ID
openalex   +1 more source

Targeting Latent HIV Reservoirs: Effectiveness of Combination Therapy with HDAC and PARP Inhibitors. [PDF]

Viruses
Tibebe H, Marquez D, McGraw A, Gagliardi S, Sullivan C, Hillmer G, Narayan K, Izumi C, Keating A, Izumi T.   +9 more
europepmc   +1 more source

Efficacy of combination therapy with mexiletine and a low dose of propranolol for premature ventricular arrhythmias.

, 1990
Akira Kobayashi, Noboru Yamazaki, Tadashi Kobayashi, Tsutomu Watanabe, Takayuki Ito, Koichi Ogawa   +5 more
openalex   +2 more sources